{
  "id": "552faababc4f83e828000005",
  "type": "factoid",
  "question": "Which translocation is the hallmark of Ewing sarcoma?",
  "ideal_answer": "Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24; 12), is detected in 95% of ES patients",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22266186",
    "http://www.ncbi.nlm.nih.gov/pubmed/10030577",
    "http://www.ncbi.nlm.nih.gov/pubmed/21422656",
    "http://www.ncbi.nlm.nih.gov/pubmed/24124617",
    "http://www.ncbi.nlm.nih.gov/pubmed/22742646",
    "http://www.ncbi.nlm.nih.gov/pubmed/23145994",
    "http://www.ncbi.nlm.nih.gov/pubmed/16864960",
    "http://www.ncbi.nlm.nih.gov/pubmed/22240531",
    "http://www.ncbi.nlm.nih.gov/pubmed/21942527",
    "http://www.ncbi.nlm.nih.gov/pubmed/16083345",
    "http://www.ncbi.nlm.nih.gov/pubmed/15919668",
    "http://www.ncbi.nlm.nih.gov/pubmed/18971581",
    "http://www.ncbi.nlm.nih.gov/pubmed/15274413",
    "http://www.ncbi.nlm.nih.gov/pubmed/6416622",
    "http://www.ncbi.nlm.nih.gov/pubmed/21653923",
    "http://www.ncbi.nlm.nih.gov/pubmed/25401475",
    "http://www.ncbi.nlm.nih.gov/pubmed/8644855",
    "http://www.ncbi.nlm.nih.gov/pubmed/24974828"
  ],
  "snippets": [
    {
      "text": "Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24; 12), is detected in 95% of ES patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124617",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ewing's sarcoma is a malignancy characterized by a specific 11:22 chromosomal translocation which generates a novel EWS-FLI1 fusion protein functioning as an aberrant transcription factor",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23145994",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hallmark of Ewing's sarcoma (EWS) is a translocation--t(11;22)(q24;q12)--that most frequently results in the EWS/FLI1 aberrant chimeric gene",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22742646",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chromosomal translocation t(11;22)(q24;q12) yields the EWS-Fli1 fusion gene, which contributes to the development of Ewing Family Tumors (EFTs)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266186",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ewing sarcoma is extremely rare in people from East and Southeast Asia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240531",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The t(11;22)(q24:q12) translocation was present in all patients in our series",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240531",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We confirmed that distant metastases is highly predictive of a poor outcome, and that the t(11;22)(q24:q12) translocation was present in all patients in our series",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240531",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The genetic hallmark of the Ewing sarcoma family of tumours (ESFT) is the presence of the t(11;22)(q24;q12) translocation, present in up to 85% of cases of ESFT, which creates the EWS/FLI1 fusion gene and results in the expression of a chimeric protein regulating many other genes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16083345",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21653923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chromosomal translocation producing the EWS/FLI1 fusion transcript characterizes clinical Ewing sarcoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21422656",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Translocation of chromosomes 11 and 22 in choroidal metastatic Ewing sarcoma detected by fluorescent in situ hybridization.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030577",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Molecular detection of the t(11;22)(q24;q12) translocation in Ewing sarcoma is valuable in the differential diagnosis of small round cell tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10030577",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This patient illustrates the second reported occurrence of primary Ewing sarcoma in the stomach and the first reported with the t(11;22)(q24;q12) gene translocation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18971581",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Translocations involving ETS-transcription factors, most commonly leading to the EWSR1-FLI1 fusion protein, are the hallmark of Ewing sarcoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24974828",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "EWS-Fli1, a fusion gene resulting from a chromosomal translocation t(11;22, q24;q12) and found in Ewing sarcoma and primitive neuroectodermal tumors, encodes a transcriptional activator and promotes cellular transformation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15919668",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The presence of the t(11;22)(q24;ql2) translocation should probably not be considered diagnostic of Ewing sarcoma and peripheral primitive neuroectodermal tumor in the absence of supporting histological evidence.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8644855",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ewing sarcoma is the prototypical member of this group of sarcomas; it was the first to be recognized pathologically as a singular entity and to have its signature translocation defined cytogenetically, which led to the identification of its key driver alteration, the EWS-FLI1 gene fusion that encodes this aberrant, chimeric transcription factor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21942527",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hallmark of Ewings sarcoma (EWS) is a translocation--t(11;22)(q24;q12)--that most frequently results in the EWS/FLI1 aberrant chimeric gene.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22742646",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ewing sarcoma family of tumors (ESFTs) are characterized by the t(11;22)(q24;q12) translocation that generates the Ewing sarcoma breakpoint region 1 and Friend leukemia virus integration 1 (EWS-FLI1) fusion transcription factor responsible for the highly malignant phenotype of this tumor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21653923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This patient illustrates the second reported occurrence of primary Ewing sarcoma in the stomach and the first reported with the t(11;22)(q24;q12) gene translocation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18971581",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnosis is based on history, immunostaining with at least 2 neural markers, ultrastructural examination, and evidence of an abnormal t(11;22)(q24;q12) translocation as the hallmark for the Ewing's sarcoma family.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15274413",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The translocation results in the fusion of the EWS gene with the transcription factor gene FLI1 which has been considered a hallmark of ESFT.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16864960",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "[Chromosomal translocation (11; 22) in cell lines of Ewing's sarcoma].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6416622",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "These results, associated with those obtained at the same time and independently from fresh tumor cells, suggest that the translocation t(11; 22)(q24; q12) may be a chromosomal marker characteristic of Ewing sarcoma cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6416622",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Chromosomal translocation that results in fusion of the genes encoding RNA-binding protein EWS and transcription factor FLI1 (EWS-FLI1) is pathognomonic for Ewing sarcoma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25401475",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnosis is based on history, immunostaining with at least 2 neural markers, ultrastructural examination, and evidence of an abnormal t(11;22)(q24;q12) translocation as the hallmark for the Ewing's sarcoma family",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15274413",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Translocations involving ETS-transcription factors, most commonly leading to the EWSR1-FLI1 fusion protein, are the hallmark of Ewing sarcoma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24974828",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The genetic hallmark of the Ewing sarcoma family of tumours (ESFT) is the presence of the t(11;22)(q24;q12) translocation, present in up to 85% of cases of ESFT, which creates the EWS/FLI1 fusion gene and results in the expression of a chimeric protein regulating many other genes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16083345",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The translocation results in the fusion of the EWS gene with the transcription factor gene FLI1 which has been considered a hallmark of ESFT",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16864960",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.disease-ontology.org/api/metadata/DOID:3368",
    "http://www.disease-ontology.org/api/metadata/DOID:4980",
    "http://www.disease-ontology.org/api/metadata/DOID:4232",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012512"
  ],
  "exact_answer": "translocation t(11;22) (q24;12)"
}